ATS Statement. Snowbird workshop on standardization of spirometry. Am Rev Respir Dis1979;119:831–838.
2.
SorensenJB, MorrisAH, CrapoRO, GardnerRM. Selection of the best spirometric values for interpretation. Am Rev Respir Dis1980;122:802–805.
3.
MungallIPF, HainsworthR.Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax1979;34:254–258.
4.
RozasCJ, GoldmanAL. Daily spirometric variability in normal subjects and subjects with chronic bronchitis with and without airflow obstruction. Arch Intern Med1982;142:1287–1291.
5.
HrubyJ, ButlerJ.Variability of routine pulmonary function tests. Thorax1975;30:548–553.
6.
Report of the Committee on Emphysema of the American College of Chest Physicians. Criteria for the assessment of reversibility in airways obstruction. Chest1974;65:552–553.
7.
SourkRL, NugentKM. Bronchodilator testing: Confidence intervals derived from placebo inhalations. Am Rev Respir Dis1983;128:153–157.
8.
EliassonO, DegraffAC. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trails. Am Rev Respir Dis1985;132:858–864.
9.
RamsdellJW, TisiGM. Determination of bronchodilatation in the clinical pulmonary function laboratory: Role of changes in static lung volumes. Chest1979;76:622–628.
10.
AyresJM, GriesbachSJ, ReimoldF, EvansRG. Bronchial component in chronic obstructive lung disease. Am J Med1974;57:183–191.
11.
GirardWM, LightRW. Should the FVC be considered in evaluating response to bronchodilator?Chest1983;84:87–89.
12.
KnudsonRJ, LebowitzMD, SlatinRC. Timing of the forced vital capacity. Am Rev Respir Dis1979;119:315–318.
13.
TownsendMC, Du CheneAG, FallatRJ. Effects of underrecorded forced expirations on spirometric lung function indexes. Am Rev Respir Dis1982;126:734–737.
14.
GelbAF, WilliamsAJ, ZamelN.Spirometry: FEV1 vs FEF25-75%. Chest1983;84:473–474.
15.
SobolBJ. Maximal midexpiratory flow: A reexamination. Am Rev Respir Dis1965;92:914–918.
16.
CockcroftDW, BerscheidBA. Volume adjustment of maximal midexpiratory flow. Chest1980;78:595–600.
17.
OlsenCR, HaleFC. Method for interpreting acute response to bronchodilators from the spirogram. Am Rev Respir Dis1968;98:301–302.
18.
NewballHH. Unreliability of the maximal midexpiratory flow as an index of acute airway changes. Chest1975;67:311–314.
19.
SherterCB, ConnollyJJ, SchilderDP. Significance of volume-adjusting the maximal midexpiratory flow in assessing response to a bronchodilator drug. Chest1978;73:568–571.
20.
StinsonJM, McPhersonGL, DarveauxR.Use of the isovolume FEF25-75% to assess small airway obstruction. Respir Care1980;25:59–62.
